drug protocol number

ICRG 1201

drug sponsor

ICR Group - International Cancer Research group

drug study

palbociclib fulvestrant

drug trial site

King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz University Hospital (Jeddah)

drug status

Ongoing

drug phase